Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 years: a quality control study

Peer Review reports

Original Submission
30 Aug 2013	Submitted	Original manuscript
1 Oct 2013	Reviewed	Reviewer Report - Tibor Tot
30 Oct 2013	Reviewed	Reviewer Report - Sara Bravaccini
3 Nov 2013	Author responded	Author comments - Zsuzsanna Varga
Resubmission - Version 2
3 Nov 2013	Submitted	Manuscript version 2
Publishing
12 Dec 2013	Editorially accepted
30 Dec 2013	Article published	10.1186/1471-2407-13-615

Back to article page